Debbie Albin

Statistics

Publications

Citations

198

H-Index

Active since

2021

Affiliations

University of Pittsburgh(Current)

UPMC Health System

Berry & Associates (United States)

University of Pittsburgh Medical Center

Debbie Albin is an author at University of Pittsburgh specializing in monoclonal antibody therapy, therapeutic monoclonal antibodies, and antibody therapeutic efficacy.

Publications per year

2021–2022

Publications

Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge

David T. Huang, Erin K McCreary, J Ryan Bariola et al. · JAMA Network Open · 2022 · 53 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19

Erin K McCreary, J Ryan Bariola, Richard J. Wadas et al. · JAMA Network Open · 2022 · 36 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +14

The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial

Erin K McCreary, J Ryan Bariola, Tami Minnier et al. · Contemporary Clinical Trials · 2022 · 26 citations · Full text

Pharmacy, Infectious Diseases, Internal Medicine +8

Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy

Erin K. McCreary, Lara Lemon, Christina Megli et al. · Annals of Internal Medicine · 2022 · 17 citations · Full text

Pharmacy, Immunology, Infectious Diseases +15

Effectiveness of casirivimab and imdevimab, and sotrovimab during Delta variant surge: a prospective cohort study and comparative effectiveness randomized trial

David T. Huang, Erin K McCreary, J Ryan Bariola et al. · medRxiv · 2021 · 15 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

1–5 of 9